Virus infection and autoimmunity: Is there a cause-and-effect relationship?

Journal of Clinical Virology

Volumn 59, Issue 3, 2014, Pages 137-140

  Magira, Eleni E ^a   Pitsolis, Theodoros ^a   Delimpasi, Sosana ^b   Vourlakou, Christina ^b   Vlachoyiannopoulos, Panayiotis ^a   Zakynthinos, Spyros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Cytomegalovirus; Scleroderma renal crisis; Ventilator associated pneumonia

Indexed keywords

CYTOMEGALOVIRUS; SCLERODERMA RENAL CRISIS; VENTILATOR-ASSOCIATED PNEUMONIA;

AUTOIMMUNITY; COLITIS; CORNEA; CORNEAL DISEASES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; LENGTH OF STAY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RAYNAUD DISEASE; VENTILATOR WEANING;

EID: 84893944365     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.08.002     Document Type: Note

References (19)

1. Steen V.D., Mayes M.D., Merkel P.A. Assessment of kidney involvement. Clinical and Experimental Rheumatology 2003, 21(Suppl. 29):S29-S31.
2. Gouge S.F., WilderK, Welch P., Sabnis S.G., Antonovich T.T. Scleroderma renal crisis prior to scleroderma. American Journal of Kidney Diseases 1989, 3:236-238.
3. Zwettler U., Andrassy K., Waldherr R., Ritz E. Scleroderma renal crisis as a presenting feature in the absence of skin involvement. American Journal of Kidney Diseases 1993, 1:53-56.
4. Gonzalez E.A., Schmulbach E., Bastani B. Scleroderma renal crisis with minimal skin involvement and no serologic evidence of systemic sclerosis. American Journal of Kidney Diseases 1994, 2:317-319.
5. Molina J.F., Anaya J.M., Cabrera G.E., Hoffman E., Espinosa L.R. Systemic sclerosis sine scleroderma: an unusual presentation in scleroderma renal crisis. Journal of Rheumatology 1995, 3:557-560.
6. Matsuyama T., Kuwana M., Matsumoto M., Isonishi A., Inokuma S., Fujimura Y. Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases. Journal of Thrombosis and Haemostasis 2009, 102:371-378.
7. Papazian L., Fraisse A., Garbe L., Zandotti C., Thomas P., Saux P., et al. Cytomegalovirus. An unexpected cause of ventilator-associated pneumonia. Anesthesiology 1996, 84:280-287.
8. Papazian L., Thomas P., Bregeon F., Garbe L., Zandotti C., Saux P., et al. Open lung biopsy in patients with acute respiratory distress syndrome. Anesthesiology 1998, 88:935-944.
9. Papazian L., Doddoli C., Chetaille B., Gernez Y., Thirion X., Roch A., et al. A contributive result of open-lung biopsy improves survival in acute respiratory distress syndrome patients. Critical Care Medicine 2007, 35:755-762.
10. Jaber S., Chanques G., Borry J., Souche B., Verdier R., Perrigault P.F., et al. Cytomegalovirus infection in critically ill patients: associated factors and consequences. Chest 2005, 127:233-241.
11. Dowling J.N., Saslow A.R., Armstrong J.A., Ho M. Cytomegalovirus infection in patients receiving immunosuppressive therapy for rheumatologic disorders. Journal of Infectious Diseases 1976, 133:399-408.
12. Boivin G., Olson C.A., Quirk M.R., Kringstad B., Hertz M.I., Jordan M.C. Quantitation of cytomegalovirus DNA and characterization of viral gene expression in bronchoalveolar cells of infected patients with and without pneumonitis. Journal of Infectious Diseases 1996, 173:1304-1312.
13. Chemaly R., Lieberman B.Y., Chapman J., Reilly A., Bekele B.N., Gordon S.M., et al. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients. American Journal of Transplantation 2005, 5:544-548.
14. Miggins M., Hasan A., Hohmann S., Southwick F., Casella G., Schain D., et al. The potential influence of common viral infections diagnosed during hospitalization among critically ill patients in the United States. PLoS ONE 2011, 6:e18890.
15. Pandey J.P., LeRoy E.C. Human cytomegalovirus and the vasculopathies of autoimmune diseases (especially scleroderma), allograft rejection, and coronary restenosis. Arthritis & Rheumatism 1998, 41:10-15.
16. Grefte A., van der Giessen M., van Son W., The T.H. Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. Journal of Infectious Diseases 1993, 167:270-277.
17. Jimenez S.A., Derk C.T. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Annals of Internal Medicine 2004, 140:37-50.
18. Sakkas L.I. New developments in the pathogenesis of systemic sclerosis. Autoimmunity 2005, 38:113-116.
19. Neidhart M., Kuchen S., Distler O., Bruhlmann P., Michel B.A., Gay R.E., et al. Increased serum levels of antibodies against human cytomegalovirus and prevalence of autoantibodies in systemic sclerosis. Arthritis & Rheumatism 1999, 42:389-392.